更正：Bio-Rad实验室第三季度每股收益2.26美元超过1.93美元的预期，销售额6.530亿美元超过6.51301亿美元的预期

Bio-Rad Laboratories (NYSE: BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1.93 by 16.92 percent. This is a 11.88 percent increase over earnings of $2.02 per share from the same period last year. The company reported quarterly sales of $653.000 million which beat the analyst consensus estimate of $651.301 million by 0.26 percent. This is a 0.50 percent increase over sales of $649.729 million the same period last year.